Ingredient record · Blood pressure medicine (ACE inhibitor)
Ramipril: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
3 entries containing Ramipril are on India's banned-drugs list, and 2 are banned today. 36 batches of medicines containing Ramipril failed a government lab test between January 2019 and July 2026, from 28 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
2
Banned combinations in force
1
Other listed orders (stayed, restricted, quashed)
36
Batches failed a lab test
Jul 2026
Latest lab alert
On the banned-drugs list
Ramipril on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Metoprolol Succinate 23.75mg (eq. to Metoprolol Tartrate 25mg) + Ramipril 2.5mg TabletFixed-dose combination · cardiac | Halted | CDSCO F.No. 4-01/2023-DC (Misc. 3) dated 11.04.2025, Annexure Sr. 21 | 11 April 2025 | 35 FDCs · Apr 2025 | CDSCO direction to state licensing authorities, 11 Apr 2025, not a Section 26A gazette ban |
| Telmisartan + Ramipril + HydrochlorothiazideFixed-dose combination · cardiac | Banned | S.O. 252(E) | 11 January 2019 | Other orders | One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021. |
| Hydrochlorothiazide + Ramipril + Losartan PotassiumFixed-dose combination · cardiac | Banned | S.O. 259(E) | 11 January 2019 | Other orders | One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021. |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Ramipril | 23 | 20 | Jul 2026 |
| Ramizim | 4 | 1 | Apr 2020 |
| Ramipril Metoprolol Succinate Sustain Release | 1 | 1 | Nov 2025 |
| Ramipril Metoprolol Succinate | 1 | 1 | Dec 2024 |
| Ramipril Hydrochlorthiazide | 1 | 1 | May 2024 |
| Ramirav | 1 | 1 | Dec 2022 |
| Ramze | 1 | 1 | Feb 2021 |
| Ramigal | 1 | 1 | Jul 2020 |
| Cadpril | 1 | 1 | Nov 2019 |
| Ramipril Tablts | 1 | 1 | Oct 2019 |
| Ramipril Ramizim | 1 | 1 | May 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Ramipril Tablets IP 5mg | R25183701KMfg 2025-11 · Exp 2027-10 | Reltsen Health CarePuducherry | Ramipril (64.20%)Other | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
| Ramipril Tablets IP 2.5 mg | TA26022Mfg 2026-01 · Exp 2027-12 | Saintlife Pharmaceuticals LtdUttarakhand | The sample does not conform to the IP with respect to Assay.Assay | DTL JaipurState lab | May 2026 |
| Ramipril Tablets IP 2.5 mg | BPRA25002Mfg 2025-04 · Exp 2027-03 | Ravian Life Sciences Pvt. LtdUttarakhand | Test for Dissolution and Assay for RamiprilAssay | DTL, Bengaluru, KarnatakaState lab | Apr 2026 |
| Ramipril Tablets I.P. 1.25mg | MLS-24943Mfg 2025-10 · Exp 2026-09 | Nexkem Pharmaceuticals Pvt. LtdUttarakhand | Content of Ramipril & Dissolution testDissolution | SDT&RL, BhubaneswarState lab | Apr 2026 |
| Ramipril Tablets IP 2.5 MG | PT-51725Mfg 2025-05 · Exp 2027-04 | Pharmaroots HealthcareHimachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to the test of Dissolution and Assay of RamiprilAssay | RDTL, ChandigarhCDSCO lab | Mar 2026 |
| Ramipril Tablets IP 5 mg | TGT25-165Mfg 2025-07 · Exp 2027-06 | Athens Life Sciences Mauza Rampur JattanHimachal Pradesh | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua J & KState lab | Nov 2025 |
| Ramipril Tablets IP 2.5 mg | PT-44206Mfg 2024-12 · Exp 2026-11 | Pharmaroots HealthcareHimachal Pradesh | Test for Dissolution & Assay for RAmiprilAssay | RDTL, Hubli, KarnatakaState lab | Nov 2025 |
| Ramipril Tablets IP | SD-1457Mfg 2025-07 · Exp 2027-06 | Sano-Cito Therapeutics IncHimachal Pradesh | The sample does not conform to the IP with respect to Assay and DissolutionAssay | DTL, JaipurState lab | Nov 2025 |
| Ramipril Tablets IP | GVD0644Mfg 2025-01 · Exp 2025-12 | Ved Lifesavers (P) LtdUttarakhand | The sample does not conform to the claim with respect to Assay & DissolutionAssay | DTL, JaipurState lab | Nov 2025 |
| Ramipril & Metoprolol Succinate Sustain Release Tablets | T24K554AMfg 2024-11 · Exp 2026-10 | Bajaj FormulationUttarakhand | The sample does not conform to the claim with respect to Assay of RamipriAssay | DTL, JaipurState lab | Nov 2025 |
| Ramipril Tablets IP (Rexre-2.5) | MB-13247Mfg 2025-01 · Exp 2027-12 | Medistream Bioscience | Sample does not conform IP standard as it fails the test Dissolution and Assay of RamipirilAssay | DTL, Thrissur, KeralaState lab | Oct 2025 |
| Ramipril Tablets IP 5mg | NHD24605AMfg 2024-12 · Exp 2026-11 | Nest Healthcare Pvt.LtdGujarat | Assay of Ramipril.Assay | CDTL, IndoreCDSCO lab | Jul 2025 |
| Ramipril Tablets IP 5 mg | TPT- 0102040Mfg ? · Exp ? | Tanpal Pharmaceuticals | Assay of RamiprilAssay | RDTL ChandigarhCDSCO lab | Jan 2025 |
| Ramipril & Metoprolol Succinate Tablets (Ramigan -MT 2.5/ 25 Tablets) | AOT23322Mfg 2023-06 · Exp 2025-05 | Astonea Labs Pvt. LtdHaryana | "Assay of Ramipril"Assay | CDTL MumbaiCDSCO lab | Dec 2024 |
| Ramipril Tablets I.P. 2.5 mg | RT-231084Mfg 2023-10 · Exp 2025-09 | Relief Biotech Pvt. LtdDelhi | Assay of RamiprilAssay | RDTL GuwahatiCDSCO lab | Sep 2024 |
Showing 15 of 36 records
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.